Prescient Healthcare Acquires Dolon to Expand Pricing and Market Access Capabilities
April 1, 2026
Prescient Healthcare Group acquired Dolon, a London-based consultancy focused on strategic pricing and market access for rare diseases and oncology. The deal strengthens Prescient’s ability to support global biopharma clients across clinical, commercial, and access decisions throughout the drug lifecycle, and expands its U.S. presence and AI-driven analytical capabilities.
- Buyers
- Prescient Healthcare Group, Bridgepoint (Bridgepoint Development Capital)
- Targets
- Dolon
- Industry
- Healthcare Services
- Location
- United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Prescient Acquires Strategic North
March 2, 2022
Consulting
Prescient, a PE-backed biopharma product and portfolio strategy consultancy, has acquired Strategic North, a UK-based commercial strategy and brand research consultancy serving pharmaceutical and biotech clients. The acquisition is an add-on to Prescient’s platform intended to deepen its commercial and brand strategy capabilities for global pharma and biotech customers.
-
Doximity Acquires Amion
February 8, 2022
Healthcare Services
Doximity, the digital platform for U.S. medical professionals, has acquired Amion, a web and mobile on-call physician scheduling application that manages nearly 200,000 physician schedules at thousands of hospitals (including 18 of the top 20). The acquisition, expected to close April 1, 2022, will integrate Amion’s scheduling capabilities into Doximity’s physician cloud platform to enhance collaboration and engagement across its products.
-
DeliverHealth Acquires PresidioHealth
March 21, 2022
Healthcare Services
DeliverHealth, a Madison-based provider of software and technology-enabled services for hospitals and health systems, has acquired San Francisco–based PresidioHealth. The acquisition integrates PresidioHealth’s SaaS coding and clinical intelligence capabilities into DeliverHealth’s platform to improve coding quality, documentation, and accelerate reimbursement for provider customers.
-
Danforth Advisors Acquires Elite BioPharma Consulting
September 6, 2023
Healthcare Services
Danforth Advisors has acquired Elite BioPharma Consulting to expand its Development Strategy & Operations (DS&O) practice, adding clinical development operations, project and trial management, clinical monitoring, program management, regulatory affairs, and medical writing capabilities. The founders of Elite will continue to lead the team as Danforth integrates Elite's expertise into its variable resource model for life science companies.
-
Prenax Acquires Couranto
June 20, 2025
Professional Services
Prenax, the Europe-headquartered subscription management firm, has acquired Couranto, a Florida-based provider of corporate subscription and information contract management services. The transaction, for which The DAK Group served as exclusive financial advisor to Couranto, expands Prenax’s capabilities and presence in the U.S., combining Prenax’s international platform with Couranto’s Discovery and Clarity solutions.
-
Red Nucleus Acquires Bridge Medical Consulting
February 5, 2026
Healthcare Services
Red Nucleus has acquired Bridge Medical Consulting, a UK-based health economics and outcomes research (HEOR) consultancy, to broaden its HEOR, real-world evidence, and market access capabilities for biopharmaceutical clients. The firm will be merged into Red Nucleus's existing HEOR business to expand evidence synthesis, economic modeling, RWE research, and AI-enabled workflows.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.